Prevention of drug diversion and substance use disorders among anesthesiologists: a narrative review

Imagem de Miniatura
Arquivos
art_FITZSIMONS_Prevention_of_drug_diversion_and_substance_use_disorders_2023.PDF (714.21 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
FITZSIMONS, Michael G.
SOUSA, Gabriel Soares de
GALSTYAN, Arpine
Citação
BRAZILIAN JOURNAL OF ANESTHESIOLOGY, v.73, n.6, p.810-818, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Diversion of substances from the care of the intended patient is a significant problem in healthcare. Patients are harmed by the undertreatment of pain and suffering, transmission of disease, as well as the risk associated with impaired vigilance. Healthcare providers may be harmed by the physical and mental impact of their addictions. Healthcare systems are placed in jeopardy by the legal impact associated with illegal routes of drug release including sanction and financial liability and loss of public trust. Healthcare institutions have implemented many measures to reduce diversion from the perioperative area. These efforts include education, medical record surveillance, automated medication dispensing systems, urine drug testing, substance waste management systems, and drug diversion prevention teams. This narrative review evaluates strengths, weaknesses, and effectiveness of these systems and provides recommendations for leaders and care providers. (c) 2023 Sociedade Brasileira de Anestesiologia.
Palavras-chave
Drug diversion, Substance abuse, Substance use disorders, Drug testing, Healthcare professionals, Anesthesiology
URI
https://observatorio.fm.usp.br/handle/OPI/57750
Referências
  1. Adaobi O. A., 2013, African Journal of Pharmacy and Pharmacology, V7, P2423
  2. Alexander BH, 2000, ANESTHESIOLOGY, V93, P922, DOI 10.1097/00000542-200010000-00008
  3. Alroy-Preis S, 2018, CLIN INFECT DIS, V67, P845, DOI 10.1093/cid/ciy193
  4. Baird CRW, 2021, ANAESTH INTENS CARE, V49, P12, DOI 10.1177/0310057X20969704
  5. Banja J, 2014, AM J BIOETHICS, V14, P25, DOI 10.1080/15265161.2014.964873
  6. Barbariol F, 2021, ANESTH ANALG, V132, P1450, DOI 10.1213/ANE.0000000000005457
  7. Bell D M, 1999, AANA J, V67, P133
  8. Berge KH, 2012, MAYO CLIN PROC, V87, P674, DOI 10.1016/j.mayocp.2012.03.013
  9. Booth JV, 2002, ANESTH ANALG, V95, P1024, DOI 10.1213/01.ANE.0000026379.66419.DB
  10. Bouffard K., 2018, UM pays $4.3M to settle federal charges for stolen drugs, but criminal charges possible
  11. Boulis S, 2015, CAN J ANESTH, V62, P964, DOI 10.1007/s12630-015-0404-1
  12. Bozimowski Gregory, 2014, AANA J, V82, P277
  13. Brenn BR, 2015, AM J HEALTH-SYST PH, V72, P1365, DOI 10.2146/ajhp140691
  14. Breve F, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.22564
  15. Brummond Philip W, 2017, Am J Health Syst Pharm, V74, P325, DOI 10.2146/ajhp160919
  16. Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Division of Healthcare Quality Promotion (DHQP), 2018, Drug Diversion
  17. Chaudhary Kapil, 2012, J Anaesthesiol Clin Pharmacol, V28, P56, DOI 10.4103/0970-9185.92438
  18. Clark J, 2022, AM J HEALTH-SYST PH, DOI 10.1093/ajhp/zxac246
  19. Darbishire PL, 2019, AM J PHARM EDUC, V83, DOI 10.5688/ajpe6576
  20. de Sousa GS, 2021, BRAZ J ANESTHESIOL, V71, P326, DOI 10.1016/j.bjane.2021.03.006
  21. de Vries M, 2022, J PATIENT SAF, V18, pE227, DOI 10.1097/PTS.0000000000000744
  22. Department of Health & Human Services Centers for Medicare & Medicaid Services, 2012, Drug Diversion in the Medicaid Program. State Strategies for Reducing Prescription Drug Diversion in Medicaid
  23. Draime JA, 2018, J AM PHARM ASSOC, V58, P275, DOI 10.1016/j.japh.2018.02.009
  24. Epstein RH, 2007, ANESTH ANALG, V105, P1053, DOI 10.1213/01.ane.0000281797.00935.08
  25. Epstein RH, 2017, JT COMM J QUAL PATIE, V43, P396, DOI 10.1016/j.jcjq.2017.02.010
  26. Epstein RH, 2011, ANESTH ANALG, V113, P160, DOI 10.1213/ANE.0b013e31821c0fce
  27. Fan M, 2019, J HOSP MED, V14, P419, DOI 10.12788/jhm.3228
  28. Fitzsimons MG, 2008, ANESTH ANALG, V107, P630, DOI 10.1213/ane.0b013e318176fefa
  29. Fitzsimons MG, 2021, ANESTH ANALG, V132, P916, DOI 10.1213/ANE.0000000000005350
  30. Fitzsimons MG, 2018, ANESTHESIOLOGY, V129, P821, DOI 10.1097/ALN.0000000000002348
  31. Fitzsimons MG, 2013, J CLIN ANESTH, V25, P669, DOI 10.1016/j.jclinane.2013.05.009
  32. Fry RA, 2015, ANAESTH INTENS CARE, V43, P111, DOI 10.1177/0310057X1504300117
  33. GRAVENSTEIN JS, 1983, ANESTH ANALG, V62, P467
  34. Grissinger Matthew, 2018, P T, V43, P714
  35. Hellinger WC, 2012, ANN INTERN MED, V156, P477, DOI 10.7326/0003-4819-156-7-201204030-00002
  36. Katz JD, 2017, CURR OPIN ANESTHESIO, V30, P217, DOI 10.1097/ACO.0000000000000423
  37. Knight T, 2022, AM J HEALTH-SYST PH, V79, P1345, DOI 10.1093/ajhp/zxac035
  38. LANGE WR, 1994, AM J DRUG ALCOHOL AB, V20, P35, DOI 10.3109/00952999409084055
  39. Lien CA, 2012, MAYO CLIN PROC, V87, P607, DOI 10.1016/j.mayocp.2012.05.004
  40. LUTSKY I, 1993, CAN J ANAESTH, V40, P915, DOI 10.1007/BF03010092
  41. LUTSKY I, 1991, ACAD MED, V66, P164, DOI 10.1097/00001888-199103000-00009
  42. Mankes RF, 2013, SCI TOTAL ENVIRON, V444, P298, DOI 10.1016/j.scitotenv.2012.11.096
  43. Merlo LJ, 2014, AM J ADDICTION, V23, P123, DOI 10.1111/j.1521-0391.2013.12078.x
  44. MOORE AB, 1993, J OCCUP ENVIRON MED, V35, P71
  45. New K, 2014, Drug diversion in health care settings can put patients at risk for viral hepatitis
  46. Ostrowsky BE, 2002, NEW ENGL J MED, V346, P1529, DOI 10.1056/NEJMoa012370
  47. Pham JC, 2014, AM J BIOETHICS, V14, P37, DOI 10.1080/15265161.2014.969544
  48. Pham JC, 2013, JAMA-J AM MED ASSOC, V309, P2101, DOI 10.1001/jama.2013.4635
  49. Podczervinski ST, 2019, Am J Infect Control, V47, pS22
  50. Reinhold J, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj740457
  51. Reisfield GM, 2009, BIOANALYSIS, V1, P937, DOI 10.4155/BIO.09.81
  52. Schaefer MK, 2014, MAYO CLIN PROC, V89, P878, DOI 10.1016/j.mayocp.2014.04.007
  53. Schuppener LM, 2017, INFECT CONT HOSP EP, V38, P1027, DOI 10.1017/ice.2017.137
  54. Shah N, 2019, ANESTHESIOLOGY, V131, P1264, DOI 10.1097/ALN.0000000000002957
  55. Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015
  56. Tetzlaff J, 2010, J CLIN ANESTH, V22, P143, DOI 10.1016/j.jclinane.2008.12.030
  57. U.S. Attorney's Office District of Massachusetts, 2015, MGH to Pay $2.3 Million to Resolve Drug Diversion Allegations
  58. Vigoda MM, 2007, ANESTH ANALG, V105, P1061, DOI 10.1213/01.ane.0000282021.74832.5e
  59. Warner AE, 2015, AM J INFECT CONTROL, V43, P53, DOI 10.1016/j.ajic.2014.09.012
  60. Warner DO, 2020, ANESTHESIOLOGY, V133, P342, DOI 10.1097/ALN.0000000000003310
  61. Warner DO, 2013, JAMA-J AM MED ASSOC, V310, P2289, DOI 10.1001/jama.2013.281954
  62. Wischmeyer PE, 2007, ANESTH ANALG, V105, P1066, DOI 10.1213/01.ane.0000270215.86253.30

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - ODS/03
Carregar mais